Structures by: Aravindan P. G.
Total: 22
C15H16NO2,C10H7O3S,2(H2O)
C15H16NO2,C10H7O3S,2(H2O)
RSC Adv. (2014)
a=16.9655(8)Å b=8.3200(4)Å c=17.1232(8)Å
α=90.00° β=106.275(2)° γ=90.00°
<i>L</i>-Tryptophan--fumaric acid--water (1/1/1)
C11H12N2O2,C4H4O4,H2O
Acta Crystallographica Section E (2015) 71, 9 o661-o662
a=11.3928(8)Å b=6.6476(4)Å c=21.4219(13)Å
α=90° β=95.801(3)° γ=90°
3,3,6,6-Tetramethyl-9-(4-pyridyl)-3,4,6,7,9,10-hexahydro- 1,8(2H,5H)-acridinedione monohydrate
C22H26N2O2,H2O
Acta Crystallographica Section E (2003) 59, 5 o659-o661
a=9.1333(5)Å b=9.8999(5)Å c=12.0435(7)Å
α=74.8760(10)° β=81.7050(10)° γ=73.1370(10)°
N,N-Dimethyl-N'-phenylformamidinium perchlorate
C9H13N2ClO4
Acta Crystallographica Section E (2003) 59, 5 o662-o664
a=7.8382(2)Å b=17.5688(6)Å c=9.1123(2)Å
α=90.00° β=113.2690(10)° γ=90.00°
9, 17-Dioxa-1,3-dithiatetracyclo[18. 2. 2. 2^23, 24^. 1^25^] heptacosan-5, 7, 11,13, 15 (25), 18, 20, 23, 26 nonene
C23H22O2S2
Acta Crystallographica Section E (2003) 59, 11 o1677-o1679
a=9.995(5)Å b=10.372(7)Å c=10.508(5)Å
α=101.84(5)° β=91.14(5)° γ=109.01(5)°
C-halogen...π interaction: 4-Chloro-2-(9-ethylcarbazol-3-yl)quinoline-1(2H)- carbaldehyde.
C24H19ClN2O
Acta Crystallographica Section E (2003) 59, 10 o1564-o1566
a=9.4147(8)Å b=9.6714(8)Å c=11.1245(9)Å
α=85.3360(10)° β=70.2350(10)° γ=84.351(2)°
6a,14a-cis-6,6a,7,14a-Tetrahydrochromeno[4',3':3,4]pyrano[3,2-c]coumarin
C19H14O4
Acta Crystallographica Section E (2003) 59, 9 o1395-o1397
a=12.22520(10)Å b=16.3351(3)Å c=15.3425(3)Å
α=90.00° β=109.2070(10)° γ=90.00°
1,2-Bis(2,4-dinitrophenoxy)ethane
C14H10N4O10
Acta Crystallographica Section E (2004) 60, 11 o2056-o2058
a=6.88760(10)Å b=13.92890(10)Å c=16.5396(5)Å
α=90.00° β=95.146(3)° γ=90.00°
4'-methoxy-4-methoxycarbonyl-2,6-dinitrostilbene
C17H14N2O7
Acta Crystallographica Section E (2004) 60, 11 o2053-o2055
a=12.0496(8)Å b=7.0295(5)Å c=19.8296(13)Å
α=90.00° β=100.8560(10)° γ=90.00°
3-phenyl-4a,5-dihydro-1,2,4-triazolo[3,4-b][1,3]benzothiazine
C15H11N3S
Acta Crystallographica Section E (2003) 59, 5 o622-o624
a=11.5674(15)Å b=10.1948(19)Å c=21.433(3)Å
α=90.00° β=90.00° γ=90.00°
3,4:9,10-dibenzo-1,12-diformyl-5,8-dioxododecane
C16H14O4
Acta Crystallographica Section E (2003) 59, 6 o806-o807
a=7.7956(7)Å b=8.4511(8)Å c=11.4697(11)Å
α=83.054(2)° β=75.008(2)° γ=67.219(2)°
3-(1-Phenylsulfonyl-2-methylindol-3-ylcarbonyl)propanoic acid
C19H17NO5S
Acta Crystallographica Section E (2003) 59, 6 o875-o877
a=8.1825(2)Å b=9.97580(10)Å c=12.31210(10)Å
α=69.2810(10)° β=72.0670(10)° γ=70.8780(10)°
5''-Benzylidene-1',1''-dimethyl-4'-phenyl-acenapthene-2-spiro-2'- pyrrolidine-3'-spiro-3''-piperidine-1,4''-dione
C34H30N2O2
Acta Crystallographica Section E (2004) 60, 11 o2149-o2151
a=16.66090(10)Å b=10.4558(9)Å c=17.4457(2)Å
α=90.00° β=116.5890(10)° γ=90.00°
1'-Methyl-4'-phenyl-9H-fluorene-9-spiro-3'-pyrrolidine-2'-spiro-3''- 1H-indol-2''(3''H)-one
C30H24N2O
Acta Crystallographica Section E (2004) 60, 11 o2152-o2154
a=18.17520(10)Å b=13.6193(9)Å c=18.48700(10)Å
α=90.00° β=90.00° γ=90.00°
3-Chloro-3-(9-ethyl-6-methyl-9H-carbazol-3-yl)propenal
C18H16ClNO
Acta Crystallographica Section E (2003) 59, 9 o1432-o1434
a=7.3191(7)Å b=8.9264(9)Å c=12.2024(12)Å
α=105.247(2)° β=91.771(2)° γ=104.378(2)°
1'-Phenyl-2',3',5',6',7',7a'-hexahydroindan-2-spiro-2'-1H-pyrrolizidine-3'- spiro-11'-indeno[1,2-b]quinoxaline-1,3-dione
C35H25N3O2
Acta Crystallographica Section E (2005) 61, 10 o3124-o3126
a=11.1149(14)Å b=12.4670(16)Å c=18.646(2)Å
α=90.00° β=99.415(2)° γ=90.00°
2-Cyano-3-dimethylamino-N-(4-methylphenyl) acrylamide
C13H15N3O
Acta Crystallographica Section C (2003) 59, 7 o394-o396
a=7.5846(3)Å b=22.4477(10)Å c=7.5989(3)Å
α=90.00° β=106.3060(10)° γ=90.00°
2-cyano-3-dimethylamino-N-(2-methoxyphenyl) acrylamide
C13H15N3O2
Acta Crystallographica Section C (2003) 59, 7 o394-o396
a=7.5141(3)Å b=12.7580(6)Å c=13.9381(6)Å
α=90.00° β=92.7950(10)° γ=90.00°
(3<i>E</i>,5<i>E</i>)-1-Benzyl-3,5-dibenzylidenepiperidin-4-one
C26H23NO
Acta Crystallographica Section E (2009) 65, 11 o2775
a=6.3354(4)Å b=10.2365(6)Å c=15.7885(9)Å
α=75.245(2)° β=87.651(3)° γ=88.699(3)°
(3<i>E</i>,5<i>E</i>)-1-Benzyl-3,5-bis(2-fluorobenzylidene)piperidin-4-one
C26H21F2NO
Acta Crystallographica Section E (2009) 65, 11 o2667
a=6.7738(4)Å b=12.5652(7)Å c=12.8535(7)Å
α=71.0510(10)° β=88.057(2)° γ=89.117(2)°
(3<i>E</i>,5<i>E</i>)-3,5-Bis(4-allyloxybenzylidene)-1-benzylpiperidin-4-one
C32H31NO3
Acta Crystallographica Section E (2009) 65, 12 o3062
a=15.6161(4)Å b=9.2654(2)Å c=18.9696(5)Å
α=90.00° β=111.0310(10)° γ=90.00°
(<i>E</i>)-4-[2-(4-Ethoxyphenyl)ethenyl]-1-methylpyridinium naphthalene-2-sulfonate
C16H18NO,C10H7O3S
Acta Crystallographica Section E (2013) 69, 5 o722
a=10.8960(10)Å b=17.2838(16)Å c=11.8888(10)Å
α=90.00° β=92.752(4)° γ=90.00°